Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2021-09-10 Regulatory Filings
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
110年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. It is a short, factual regulatory disclosure without detailed financial statements or analysis. It does not contain a full report, management discussion, or audit information. The content fits the profile of a general regulatory announcement or compliance filing rather than a full financial report or announcement of voting results, dividends, or capital changes. Given the short length (602 characters) and the nature of the content, it is best classified as a Regulatory Filing (RNS).
2021-09-10 Chinese
110年9月8日內部人設質解質
Director's Dealing Classification · 95% confidence The document is a tabular report showing share pledge changes involving a company director's representative's spouse, including dates and share quantities. This matches the characteristics of a Director's Dealing report, which covers personal share transactions or related share pledges by company directors or their close associates. The document is short and factual, listing specific share pledge data, consistent with the DIRS category.
2021-09-09 Chinese
110年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. There is no indication of financial statements, earnings data, or report summaries. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification. Therefore, the appropriate classification is DIRS.
2021-09-06 Chinese
110年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and initial shareholdings, pledged shares, and related party holdings. It is from a public information observation station and includes specific data about internal persons' shareholdings. There is no financial performance data, no mention of earnings, no report publication, no voting results, no legal proceedings, no capital changes, and no management changes. The content matches the description of Director's Dealing filings, which report personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and is a direct disclosure of insider shareholdings, not an announcement or summary. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-09-06 Chinese
110年08月法人說明會簡報 — 176220210826E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Second Quarter 2021 Investor Conference' and dated August 27, 2021. It contains detailed financial data such as consolidated income statements, balance sheets, sales distribution, profitability over 5 years, and future outlook. The presence of comprehensive financial statements and analysis for a half-year period (January to June 2021) indicates this is a financial report for a period shorter than a full fiscal year. The document is 7802 characters long, which is sufficient to contain substantive financial data rather than just an announcement or summary. The content aligns with an Interim / Quarterly Report rather than a brief earnings release or investor presentation. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-08-26 Chinese
110年08月法人說明會簡報 — 176220210826M001.pdf
Investor Presentation Classification · 95% confidence The document is titled '2021年第二季法人說明會' which translates to '2021 Q2 Institutional Investor Presentation'. It contains detailed financial data for the half-year period ending June 30, 2021, including consolidated income statements, balance sheets, and growth analysis. It also includes business updates, product portfolio analysis, future outlook, and company background information. The presence of detailed financial tables and forward-looking statements typical of investor presentations, combined with the document length (7,823 characters) and the nature of content focusing on financial performance and strategic outlook, indicates this is an Investor Presentation rather than a formal Interim Report or Earnings Release. There is no indication that this is a full Annual Report or a regulatory filing. Therefore, the document best fits the category of Investor Presentation (IP).
2021-08-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.